LNKB vs WST · P/E 7.9, rev $167.6M vs P/E 35, rev $1.72B
LINKBANCORP Inc (LNKB) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
LINKBANCORP Inc (LNKB) is a banks - regional company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported LNKB revenue for 2024-12-31 was $167.6M. Net income was $26.2M. Revenue was up 152.8% from 2023-12-31 to 2024-12-31. LNKB currently screens at market cap $286.7M and trailing P/E 7.9.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
LNKB currently screens at market cap $286.7M and trailing P/E 7.9. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the LNKB and WST stock pages for the full models.
Not investment advice.